Engflag

Citra

Quick links to important sections

Citra

There is no image.

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Citra

Property Description
Active Ingredients Sodium Ascorbate, Zinc Gluconate
Form Tablet, Capsule, or Oral Solution (Oral Route)
Pharmacological Class Essential Micronutrient Supplement / Vitamin and Mineral Complex
General Purpose Immune System Maintenance and Deficiency Correction
Distinctive Feature Utilizes the buffered Sodium Ascorbate salt form

What Type of Medicine is Citra and What is its Purpose?

Citra is an Over-The-Counter (OTC) combination medicine specifically classified as an Essential Micronutrient Supplement within the Vitamin and Mineral Complex pharmacological category. This product's fundamental purpose is restricted to immune system maintenance and serving as foundational support for general well-being. The formulation provides a dual source of essential nutrients intended to prevent or correct potential micronutrient deficiency. The product is designed exclusively for oral administration. The use of the buffered salt Sodium Ascorbate (rather than free ascorbic acid) is a distinctive feature of this formulation, often employed to potentially improve gastrointestinal tolerance.

Active Ingredients and Pharmaceutical Form

The medicine's identity is defined by its two key active ingredients: Sodium Ascorbate and Zinc Gluconate. Sodium Ascorbate is a high-purity, synthetic buffered salt of Ascorbic Acid (Vitamin C), which functions as a potent antioxidant in pharmaceutical applications. The second component, Zinc Gluconate, is the bioavailable salt of the trace mineral zinc, which regulatory bodies recognize for its safety and nutritional function. This combination is typically available for oral consumption in the dosage forms of a tablet, capsule, or occasionally an oral solution.

How Do Sodium Ascorbate and Zinc Gluconate Support the Body?

The general mechanism principle is based on providing nutritional cofactors essential for physiological defense and repair. Sodium Ascorbate delivers powerful antioxidant action, which helps protect cells from oxidative stress and is crucial for collagen formation, supporting the integrity of connective tissue. Zinc Gluconate supplies the essential cofactor required for numerous enzymatic processes, particularly those that govern the multiplication and function of immune cells. These physiological actions contribute to the overall benefit of maintaining a robust and efficient natural defense system.

What side effects are possible with Citra?

Citra: Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety statements for Citra as documented in authoritative government regulatory documents.

Adverse Reaction Scope

Category Description based on Regulatory Classification
Adverse Reaction Categories Adverse effects are systematically grouped by their frequency in clinical trials and by the System-Organ Class (SOC) affected (e.g., Nervous System Disorders, Gastrointestinal Disorders).
Frequency Classification Adverse reactions are classified using standard frequency bands: Very Common (1/10), Common (1/100 to < 1/10), Uncommon (1/1,000 to < 1/100), Rare (1/10,000 to < 1/1,000), Very Rare (< 1/10,000), and Not Known.
Serious Adverse Reactions (SARs) The official label documents specific medically severe reactions. Examples include rare occurrences of Anaphylactic Shock, Severe Hepatotoxicity, or documented risk of QT Prolongation/Torsade de Pointes.
Population-Specific Safety Safety considerations are established for certain patient populations. For example, specific cautions or required monitoring may be noted for patients with severe renal or hepatic impairment, or for use during pregnancy.
Exposure-Related Patterns Regulatory documents may note safety concerns tied to the duration of use, such as an increased risk of peripheral neuropathy with prolonged treatment, or the risk of withdrawal symptoms upon abrupt cessation after extended therapy.

Safety-Related Restrictions and Limitations

  • Contraindications: Use of Citra is expressly forbidden under certain conditions, such as known hypersensitivity to the drug or concurrent administration with strong inhibitors of the CYP3A4 enzyme, as specified in the official labeling.
  • Monitoring Notes: The label dictates that mandatory periodic monitoring of certain clinical parameters, such as liver function tests, is required for all patients during initial therapy.

The regulatory framework strictly defines the drug’s risk profile by categorizing all known adverse reactions by incidence and severity. This structure provides a transparent overview of the documented side effects, moving from common, less severe issues to the formally classified serious, rare risks, thereby establishing clear constraints on safe use.

Overdose and Emergency Response

Overdose: Official Regulatory Information

Official regulatory information describes overdose presentations associated with certain 'Citra' compounds, which include risks ranging from severe central nervous system depression to cardiovascular irregularities. These descriptions are based on governmental documents for drugs such as Citalopram (an antidepressant) and Fentanyl Citrate (an opioid).

Documented Overdose Presentations and Manifestations:

Physiological Systems Affected Documented Overdose Signs
Central Nervous System (CNS) / Respiratory Life-threatening respiratory depression, coma, seizures, extreme drowsiness, confusion, agitation, or hallucinations.
Cardiovascular Fast, irregular heartbeat, chest pain, and fainting.

Circumstances and Risk Factors:

Overdose risk for opioid forms is significantly increased by co-administration with other Central Nervous System depressants, including alcohol. For certain compounds, severe cardiovascular symptoms, such as long QT interval prolongation, are considered dose-dependent risks. In particular, the ingestion of even a single dose of certain high-potency forms by non-prescribed individuals, especially children, can be fatal.

When Immediate Medical Help is Required:

Any suspected overdose is a medical emergency. Immediately call emergency services at 911 if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Contact a physician or seek emergency medical treatment right away if any severe symptoms occur, including uncharacteristic drowsiness, slow or weak breathing, severe muscle stiffness, or rapid heartbeat. For high-risk opioid forms, resuscitation equipment and an antidote are required to be readily available by trained personnel.

Therapeutic Uses of Citra

What Citra Treats: Main Uses and Benefits

Citra, a combination of Sodium Ascorbate and Zinc Gluconate, is generally used across therapeutic domains where additional symptomatic support is needed due to nutritional status or heightened physiological stress. Ascorbic acid plays a role in managing processes related to tissue repair and nutrient utilization, and supports general well-being.

The supplement is applied in addressing both confirmed Vitamin C and Zinc deficiencies, and for supportive relief during acute seasonal symptoms such as the common cold, where fatigue and malaise become noticeable. Providing these essential micronutrients may help patients cope more steadily with symptom fluctuations and supports general well-being.

Supportive Relief and Deficiency Correction

This formulation is commonly used across conditions presenting with acute episodes and in situations where dietary intake is inadequate or physiological need is heightened. It assists with maintaining functional stability by addressing deficiencies that can create noticeable physiological strain, making it relevant for promoting skin integrity and supporting the processes of tissue healing. This contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Supportive Relief for General Malaise and Fatigue

Regulatory References

  1. NIH MedlinePlus overview of Ascorbic Acid

Eligibility and Restrictions for Use

The official regulatory profile for Citra, a combination of Sodium Ascorbate and Zinc Gluconate, sets clear boundaries for use based on age, physiological conditions, and comorbidities.

Eligibility Scope

Populations for whom use is allowed:

  • Adults and adolescents 12 years of age and older.

Populations for whom use is contraindicated:

  • Individuals with known allergy or hypersensitivity to any ingredient.
  • Patients with a history of hyperoxaluria (predisposition to kidney stones), particularly when taking high doses of the ascorbic acid component.

Condition-specific eligibility rules (Conditional Use/Caution):

  • The medicine must be used with caution in patients with impaired renal function due to the potential for accumulation of metabolites and trace elements.
  • Individuals diagnosed with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency must use the product with caution due to the risk of inducing haemolysis.
  • Patients adhering to a controlled sodium diet must use the medicine with caution, as the Sodium Ascorbate salt form contributes to overall sodium intake.

Age- and physiological-related restrictions:

  • Use is generally not recommended in children under 12 years of age, as safety and effectiveness are often not established for this pediatric population.
  • For pregnancy and lactation, use is permitted at standard Recommended Dietary Allowance (RDA) levels, but the intake of high doses of ascorbic acid (>1 g daily) is restricted or not recommended.

What should I know about interactions with other medicines?

The official interaction profile for Citra, a vitamin and mineral complex, is defined by the specific chemical constraints of its active components that lead to documented pharmacokinetic and pharmacodynamic interactions. The zinc component may inhibit the absorption of several drug classes, resulting in reduced serum concentration for the interacting medicine. This effect is documented with Tetracycline-class antibiotics, Fluoroquinolone antibiotics, and HIV Integrase Inhibitors (e.g., Dolutegravir). This interaction requires a timing separation of at least 2 hours between zinc administration and these medicines, as well as with high-fiber foods or dairy products. The ascorbic acid component promotes urine acidification, which can increase the renal excretion of certain basic drugs, such as amphetamine, and decrease the plasma concentrations of drugs like Fluphenazine. Ascorbic acid is also documented to decrease the activity of certain antibiotics (e.g., Erythromycin). A separate restriction mandates that ascorbic acid not be initiated until after the first month of Deferoxamine therapy due to the documented risk of cardiovascular complications. Population-specific constraints include the potential for acute hemolysis in patients with G6PD deficiency and the caution required for patients on a sodium-restricted diet due to the Sodium Ascorbate salt.

Mechanism of Action

The pharmacological action of Citra, combining Sodium Ascorbate (Vitamin C) and Zinc Gluconate (Zinc), involves essential cofactors and antioxidants for key physiological processes that govern defense and structural integrity. The mechanisms engage distinct pathways associated with free radical neutralization and collagen synthesis.

Cellular Defense via Antioxidant Pathways

This mechanism centers on Vitamin C acting as a reducing agent that directly neutralizes free radicals (Reactive Oxygen Species) to prevent oxidative damage to cell structures. Zinc participates in this domain by acting as an essential cofactor for the body's major endogenous antioxidant enzyme system (Superoxide Dismutase). This action limits the impact of oxidative stress on cellular components, particularly those involved in the immune response.

Cofactor Provisioning for Immune Cell Maturation

Zinc is structurally required as a cofactor for numerous metalloenzymes, including those vital for DNA and RNA Polymerase activity. This role is fundamental to the Cellular Proliferation Pathway, facilitating the rapid division and specialized maturation of immune cells like T-lymphocytes and Natural Killer ( NK) cells. This mechanism facilitates the generation of specialized immune cells, contributing to the functional capacity of the immune system.

Structural Stability and Barrier Integrity

The structural mechanism involves Vitamin C acting as a key cofactor for hydroxylase enzymes necessary for the proper cross-linking and stabilization of collagen. Collagen provides the essential physical foundation for all connective tissue and maintains the structural strength of the body's epithelial and mucosal barriers, which are the physical barriers between the internal and external environments.

Dosage and Administration Information

How to Use Citrate-Based Solutions (Citra)

Official usage instructions for citrate-based oral solutions and granules are defined by standardized clinical guidelines. These guidelines dictate the required steps for administration and maintenance.

Administration and Preparation

Instruction Type Requirement
Route of Administration Oral (by mouth).
Preparation Liquid forms must be shaken well before use. Both liquid and granular forms require adequate dilution with water or juice before ingestion. Granules or crystals must be fully reconstituted (mixed) into a minimum amount of liquid.
Timing Doses must be taken after meals and again at bedtime to maintain a consistent schedule.

Dosing and Monitoring

Dosage is determined by a healthcare professional and is generally measured in teaspoonfuls (e.g., 5 to 30 mL) for adults and pediatric patients, or as the contents of a single packet for granules. For maintenance therapy, the administration frequency is typically four times a day.

  • Dose Adjustment: The prescribed dosage is not static. It must be monitored and periodically adjusted by a healthcare provider. This adjustment is guided by laboratory testing that measures the pH (acidity or alkalinity) of the urine.
  • Age-Specific Use: Specific doses are established for adults and pediatric patients; use in children under two years of age requires consultation with a physician.

This structured approach, which includes mandatory preparation, specific timing, and professional monitoring, defines the usage protocol for the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Citra

Evidence for Use in Correcting Micronutrient Deficiency

The research base for the components of Citra was evaluated in studies focusing on their role as essential micronutrients. This research includes large observational cohorts that track nutritional levels across populations, as well as randomized controlled trials (RCTs) that research examined how symptoms change over time. Studies monitored specific biomarker levels in the blood, and research examined whether supplementation was associated with a measurable shift in plasma and serum concentrations, which was observed in studies examining patient-reported outcomes describing perceived discomfort in people starting with low status.

Research describes that the individual components were studied for their relevance to functional balance and outcomes related to systemic or functional imbalance. What remains uncertain is the long-term follow-up in the general population; the long-term effects are not fully established by intervention trials. Additionally, research provides limited data regarding the comparative effects of different salt forms of these nutrients (such as Sodium Ascorbate) on absorption or long-term tolerance.

Evidence for Supportive Use During Acute Seasonal Symptoms

The research base for the components of Citra was evaluated in studies conducted during periods of increased symptom activity, such as the common cold. These studies focused on outcomes related to episodic or acute changes. Researchers examined how symptoms evolved in the observed populations, primarily monitoring outcomes related to physical discomfort, such as the duration of the common cold episode (time in days) and overall symptom severity scores, like malaise and fatigue.

Studies conducted during periods of increased symptom activity have reported how symptoms evolved in the observed populations, with some research observing responses over defined time intervals that related to shorter measured symptom duration. However, the findings related to patient-reported outcomes describing perceived discomfort were mixed and highly variable across different meta-analyses, often linked to heterogeneity in dose, formulation, and administration timing.

Understanding the Study Landscape: Consistency and Research Gaps

The overall evidence landscape for Citra's components is characterized by a high volume of data on the individual nutrients, but comparative evidence is lacking for the precise combination and formulation. Findings related to deficiency correction are generally consistent, supporting the role of these micronutrients in fundamental health maintenance.

The sample sizes were modest in some of the intervention studies, and the follow-up durations were limited for assessing sustained health outcomes. This highlights that research provides context but not individual predictions, and studies monitored responses over defined time intervals.

Key Studies & References

  1. Ascorbic Acid (Vitamin C): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Citra (FAQ)

Q: Is it normal to feel tired or weak when first starting Citra?

A: Official information indicates that side effects like fatigue and sleepiness have been reported, particularly when the ascorbic acid component is taken at high daily doses, such as 1 gram or more. Any new or concerning effects should be reviewed with a healthcare provider.

Q: What kinds of food or drinks should be avoided while taking Citra?

A: Regulatory documents recommend separating the intake of the zinc component from certain foods to potentially optimize absorption. To help maintain effective levels, the zinc component is often recommended to be taken at least 2 hours before or after consuming high-fiber foods and dairy products.

Q: Does Citra cause drowsiness or affect my ability to drive?

A: While not a common effect at standard doses, official regulatory information notes that sleepiness or lethargy has been reported as a sign of acute overdose involving very high doses of zinc (4 to 8 grams). This effect is generally not expected when the product is used within the recommended guidelines.

Q: Why is proper dilution of the liquid formulation of Citra so important?

A: The proper dilution of the liquid form with water or juice is a required step in the administration instructions. This preparation step is required as it may help mitigate potential gastrointestinal upset or discomfort that can be caused by the concentrated solution.

Q: Does Citra have an unpleasant taste that needs to be masked?

A: Official regulatory side effect data for the zinc component lists an altered sense of taste or an unpleasant taste as a potential, less serious side effect that has been reported by some users.

Q: Can I take other supplements like Vitamin D or magnesium while on Citra?

A: Regulatory information for the zinc component highlights its potential to interfere with the absorption of other minerals. Some data shows that taking excessively high doses of zinc can potentially decrease the body's absorption of magnesium. It is a standard safety measure to inform your healthcare provider about all supplements and medicines you are taking.

Q: Is Citra a prescription-only medicine?

A: According to the official product classification, Citra is designated as an Over-The-Counter (OTC) combination medicine. It falls within the category of a vitamin and mineral complex.

Q: Do I need to limit salt or sodium in my diet while taking Citra?

A: Due to the sodium content of the Sodium Ascorbate salt form used in the product, individuals on a sodium-restricted diet should discuss use with a healthcare provider before using Citra.

Q: Can Citra cause a change in mood or irritability?

A: While specific mood changes are not listed as common side effects of Citra, literature on the components indicates that severe, untreated deficiency of the zinc component has been associated with neuropsychiatric symptoms, including mood changes.

Q: What are the signs of intestinal injury, like severe stomach pain, that require urgent attention while on Citra?

A: Official safety information advises that users seek emergency medical attention. This action is required at the first sign of any severe adverse drug reaction or if a dosage greater than the recommended amount has been taken.

Q: Does Citra interact with nonsteroidal anti-inflammatory drugs (NSAIDs)?

A: The regulatory interaction information for the ascorbic acid component states that it can interfere with the absorption of aspirin, which belongs to the class of NSAIDs. It is always recommended to inform your healthcare professional of all medicines, including any NSAIDs, you are taking.

How should Citra be stored and disposed of?

Storage Conditions

Citra oral solution must be stored at Controlled Room Temperature, which is between 20°C and 25°C (68°F and 77°F). Brief temperature excursions are permitted between 15°C and 30°C (59°F and 86°F).

To ensure product integrity and safety, the medicine is required to be kept in a tightly closed container and must always be stored out of reach of children.

Disposal Instructions

Disposal of any unused or expired Citra must strictly follow all applicable federal, state, and local regulations.

If a drug take-back program is unavailable, U.S. regulatory guidelines advise mixing the product with an unappealing substance, sealing it in a container, and disposing of it in household trash. All personal information should be removed from the container label prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagEgypt

Equivalent of Citra found in:

A-Z Index: